Los puntos clave no están disponibles para este artículo en este momento.
FRANKFURT, Germany, well known across Europe for its culture, education, and above all, bustling financial district, was home to the 17 th Annual European Association for Haemophilia and Allied Disorders (EAHAD) Congress this year.The much anticipated event saw nearly 2,000 experts from around the world flock to the city of skyscrapers between 6 th -9 th February 2024 to present on the latest developments in the field, share information on current clinical research, and exchange ideas with other healthcare professionals, all to improve clinical care for patients with inherited or acquired bleeding disorders.The congress featured an enthusiastic welcome from 2024 EAHAD Congress President, Wolfgang Miesbach, who discussed the ongoing innovation and education in haemophilia research which makes EAHAD unique.He praised the collaboration and cooperation of EAHAD and other scientific centres, before going on to discuss the latest projects being undertaken by the association, such as the EAHAD Gene Therapy Working Group, and a new webinar series organised by the Nurses Committee intended to educate on the role nurses can have in treating bleeding disorders.Miesbach then turned his attention to this year's congress, highlighting several of the illuminating sessions he looked forward to attending, before closing his speech with some recommendations for first-time visitors in the city, not least that they try some traditional food, namely Grie Soß and apple wine.
EMJ EMJ (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: